HHS Secretary Kennedy Halts $500 Million in mRNA Vaccine Research Funding
HHS Secretary Robert F. Kennedy Jr. terminated $500 million for 22 mRNA vaccine projects, citing efficacy concerns against rapidly mutating viruses, a move criticized by medical experts.
Boston HeraldFACT FOCUS: RFK Jr.’s reasons for cutting mRNA vaccine not supported by evidence
PBS NewsHourFederal mRNA funding cut is 'most dangerous public health decision' ever, expert says
Associated PressFACT FOCUS: RFK Jr.'s reasons for cutting mRNA vaccine not supported by evidence
ABC NewsTrump once hailed mRNA vaccines as a 'medical miracle.' Now RFK Jr. is halting advancement
Overview
HHS Secretary Robert F. Kennedy Jr. terminated $500 million in funding for 22 mRNA vaccine development projects, marking a significant shift in public health policy regarding vaccine research.
Kennedy justified this decision by expressing concerns that mRNA vaccines may not adequately protect against rapidly mutating viruses such as COVID-19 and the flu.
The canceled projects, primarily funded by BARDA, included initiatives from Pfizer and Moderna, focusing on developing respiratory virus vaccines.
Infectious disease experts and former FDA officials credit mRNA technology, developed during the Trump administration, with significantly mitigating the 2020 coronavirus pandemic.
Leading medical experts, including Dr. Paul Offit, strongly criticized Kennedy's decision as short-sighted and potentially dangerous, warning it could leave Americans vulnerable.
Analysis
Center-leaning sources collectively frame RFK Jr.'s decision to cut mRNA vaccine funding as a detrimental and scientifically misguided move. They emphasize the broad condemnation from experts, highlighting the potential negative impacts on public health preparedness, scientific innovation, and the U.S.'s global leadership in biotechnology. The coverage consistently refutes Kennedy's scientific claims and contextualizes his actions within an "anti-vaccine agenda."